Prescription drug · NDA
Byqlovi (Clobetasol propionate) NDC 82667-021
Clobetasol propionate .5 mg/mL · For suspension · Ophthalmic · Harrow Eye, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 82667-021-00 | 8266700210082667002100 | 1 BOTTLE, PLASTIC in 1 CARTON (82667-021-00) / 3.5 mL in 1 BOTTLE, PLASTICMarketed from Jan 25, 2026 · Sample package | |
| 82667-021-05 | 8266700210582667002105 | 1 BOTTLE, PLASTIC in 1 CARTON (82667-021-05) / 3.5 mL in 1 BOTTLE, PLASTICMarketed from Jan 25, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Byqlovi
- Generic name (nonproprietary)
- clobetasol propionate
- Active ingredients
- Clobetasol propionate — .5 mg/mL
- Dosage form
- For suspension
- Route
- Ophthalmic
- Labeler
- Harrow Eye, LLCNDC labeler code 82667
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 218158
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 82667-021_494dc96c-0519-0b10-e063-6294a90ae904SPL ID 494dc96c-0519-0b10-e063-6294a90ae904SPL set ID 31ca5a0f-812e-491d-aa00-d8ed424ba322RxCUI 2683740, 2733663UNII 779619577MUPC 0382667021056
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N482667002100followed by a unit qualifier and the quantityPackage 82667-0021-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
BYQLOVI is indicated for the treatment of post-operative inflammation and pain following ocular surgery. BYQLOVI is a corticosteroid indicated for the treatment of post- operative inflammation and pain following ocular surgery. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 82667-021
- What is NDC 82667-021?
- 82667-021 is the product NDC for Byqlovi (clobetasol propionate), Clobetasol propionate .5 mg/mL for suspension, listed with the FDA by Harrow Eye, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Byqlovi (Clobetasol propionate).
- What is the active ingredient?
- Clobetasol propionate.
- Who is the labeler?
- Harrow Eye, LLC, NDC labeler code 82667. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Byqlovi?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Other NDCs under NDA 218158
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Clobetasol Propionate | Clobetasol propionate .5 mg/mL | Suspension/ dropsOphthalmic | Eyenovia, Inc. | 81046-0319 |